TLM Utility Nav

Management of Hepatocellular Carcinoma in Africa 

Description

Organized by the AASLD Global Outreach and Engagement Committee and the Society on Liver Diseases in Africa as a joint program, presenters in this session discuss the burden of HCC in Africa; current management guidelines for HCC in Africa; emerging basic science research on HCC in Africa; and current treatment approaches and ways of increasing access to systemic therapies for HCC in Africa.

 

Journey Maps

Presentations

3:45 PM - 3:50 PM
Nov 18 2024
San Diego, CA

Hepatocellular Carcinoma Clinical Case Presentation

Catherine W Spearman, PhD, Presenter
DEI
Liver Cancer
4:05 PM - 4:15 PM
Nov 18 2024
San Diego, CA

Hepatocellular Carcinoma Treatment Options and Outcomes in Sub-Saharan Africa

Catherine W Spearman, PhD, Presenter
DEI
Liver Cancer
4:15 PM - 4:25 PM
Nov 18 2024
San Diego, CA

Access to Systemic Therapies for Hepatocellular Carcinoma in Africa

Ghassan K. Abou-Alfa, Presenter
DEI
Liver Cancer
4:25 PM - 4:35 PM
Nov 18 2024
San Diego, CA

Hepatocellular Carcinoma Basic Science Research in Africa

Lewis R Roberts, MBChB, PhD, FAASLD, Presenter
DEI
Liver Cancer
4:35 PM - 4:45 PM
Nov 18 2024
San Diego, CA

Questions and Answers

Kidist K Yimam, MD, Presenter
DEI
Liver Cancer

Objectives

  • Review the burden of HCC in Africa, and risk factors and natural history.
  • Describe the current treatment approach and outcomes for HCC in Africa.
  • Discuss the limited access to systemic therapies for HCC in Africa and ways to mitigate access barriers.